Stockreport

QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF one-time administered investigational gene therapy, which is being developed to treat Huntington's disease. Huntington's disease is a genetic disorder that causes the [Read more]